Recent Advances in Intranasal Administration for Brain-Targeting Delivery
Addressing disorders related to the central nervous system (CNS) remains a complex challenge because of the presence of the blood-brain
A forum for researchers, students and applicants in the field of cyclodextrin technology
Addressing disorders related to the central nervous system (CNS) remains a complex challenge because of the presence of the blood-brain
Huntington’s disease (HD) is a progressive inherited neurodegenerative disease caused by a CAG repeat expansion in the huntingtin gene, which
With immense sadness we have to announce that an outstanding Scientist, Dr. David Begley passed away on Thursday 6th July
The complexity and organization of the central nervous system (CNS) is widely modulated by the presence of the blood–brain barrier
“4th Edition of Global Conference on Pharmaceutics and Drug Delivery Systems” (PDDS 2021) is going to be held during September
100% of patients who completed the trial improved or remained stable, and 89% met the efficacy outcome measure of improvement
Cyclolab, the oldest, world renowned cyclodextrin research, development and manufacturing company, and EpiPharma, a bio-pharmaceutical services and peptide drug development
The CDNews blog was created in July and after a short period of trial it started in September. During this
Nitric oxide (NO) is a signaling molecule produced by almost all types of organisms ranging from bacteria to plants and
A paper has just come out in Macromolecular Rapid Communications highlighting the potential benefits of cyclodextrin-based macromolecular systems as cholesterol-mopping